U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304440) titled 'Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study' on Dec. 12.
Brief Summary: This 24-month study is testing whether adding AdiaVita, an umbilical cord blood-derived stem cell and exosome product, to glutathione therapy helps improve autism symptoms in children ages 3-12 more than glutathione alone. Children will be randomly placed into one of two groups for the first three months: one group receives glutathione only, and the other receives glutathione plus monthly intravenous AdiaVita infusions. Both groups also use topical glutathione cream twice daily at home. Autism symptoms will be tracked over two years using...